Truehand Inc’s Eli Lilly LLY Stock Holding History

Truehand Inc’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.83M	Sell	6,625 -2,100	-24%	-$532K	1.07%	35
2021 Q3	$2.02M	Hold	8,725	–	–	1.19%	33
2021 Q2	$2M	Hold	8,725	–	–	1.18%	33
2021 Q1	$1.63M	Hold	8,725	–	–	1%	38
2020 Q4	$1.47M	Hold	8,725	–	–	0.97%	38
2020 Q3	$1.29M	Hold	8,725	–	–	0.93%	37
2020 Q2	$1.43M	Sell	8,725 -500	-5%	-$76.8K	1.1%	35
2020 Q1	$1.28M	Hold	9,225	–	–	1.21%	34
2019 Q4	$1.21M	Sell	9,225 -1,000	-10%	-$116K	0.92%	42
2019 Q3	$1.14M	Hold	10,225	–	–	0.89%	42
2019 Q2	$1.13M	Hold	10,225	–	–	0.86%	44
2019 Q1	$1.33M	Hold	10,225	–	–	1.01%	39
2018 Q4	$1.18M	Buy	+10,225	New	+$1.14M	1%	40

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Truehand Inc's LLY Position: Q4 2021 in Review

Truehand Inc reduced its Eli Lilly (LLY) stake by 24% in Q4 2021, selling an estimated $532K and leaving 6,625 shares worth $1.83M. The position accounts for 1.07% of the portfolio, ranked #35.

Truehand Inc first reported a position in LLY in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.02M in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

Truehand Inc held 6,625 shares of Eli Lilly worth $1.83M as of Q4 2021.
Truehand Inc sold 2,100 Eli Lilly shares in Q4 2021, an estimated $532K.
Eli Lilly made up 1.07% of Truehand Inc's portfolio in Q4 2021, its #35 holding.
Truehand Inc first reported a position in Eli Lilly in Q4 2018 and has held it in 13 quarters since.
Truehand Inc's Eli Lilly position peaked at $2.02M in Q3 2021.
2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.